4.5 Review

Hypersensitivity Reactions to Non-Steroidal Anti-Inflammatory Drugs

期刊

CURRENT PHARMACEUTICAL DESIGN
卷 22, 期 45, 页码 6784-6802

出版社

BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/1381612822666160928142814

关键词

Non-steroidal anti-inflammatory drugs; hypersensitivity reactions; cross-intolerance; selective reactions; IgE; T-cell response; classification; blended reactions

资金

  1. Institute of Health Carlos III of the Ministry of Economy and Competitiveness (European Regional Development Fund (ERDF) RIRAAF network) [RD12/0013]
  2. Consejeria de Salud de la Junta de Andalucia [PI-0463-2013]

向作者/读者索取更多资源

Non-steroidal anti-inflammatory drugs (NSAIDs) are one of the leading causes of hypersensitivity reactions to drugs, and they are classified in two groups: those induced by non-specific immunological mechanisms (non-allergic or cross-intolerance (CI) reactions), or by specific immunological mechanisms (allergic or selective reactions (SR)). The pathogenesis of CI is associated with their pharmacological activity (COX-1 inhibition), with symptoms due to an imbalance in the arachidonic acid pathway, independently of their chemical structure. SRs are mediated by specific IgE- or by a T-cell response and can be induced by a single NSAID or a class of chemically related NSAIDs, with patients tolerating chemically unrelated compounds. NSAIDs hypersensitivity reactions have been classified in five main groups: i) NSAIDs-exacerbated respiratory disease (NERD); ii) NSAIDs-exacerbated cutaneous disease (NECD); iii) NSAIDs-induced urticaria/angioedema (NIUA); iv) Single NSAID-induced urticaria/angioedema or anaphylaxis (SNIUAA); v) Single NSAID-induced delayed reactions (SNIDRs). Although this classification described above is widely accepted by most authors some phenotypes such as blended reactions do not fit. Therefore more research is needed in this topic.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据